{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T08:40:14Z","timestamp":1739436014335,"version":"3.37.0"},"reference-count":55,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2009,11,16]],"date-time":"2009-11-16T00:00:00Z","timestamp":1258329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:p><jats:bold>Background and purpose:\u2002<\/jats:bold>The aim of this study was to investigate the effect of chronic treatment with antihypertensive and non\u2010antihypertensive doses of zofenopril on cardiovascular changes in spontaneously hypertensive rats (SHR).<\/jats:p><jats:p><jats:bold>Experimental approach:\u2002<\/jats:bold>Male SHR were treated with 0.5 or 10\u2003mg\u00b7kg<jats:sup>\u22121<\/jats:sup>per day of zofenopril (Z<jats:sub>0.5<\/jats:sub>and Z<jats:sub>10<\/jats:sub>) for 3 months. SHR and Wistar\u2010Kyoto rats (WKY) receiving vehicle were used as controls. Systolic blood pressure was measured using the tail cuff method. Left ventricular weight\/body weight ratio was calculated as cardiac hypertrophy index. Angiotensin converting enzyme (ACE) activity was determined in plasma and tissues by a fluorimetric method. Vascular reactivity was evaluated on aortic rings by acetylcholine and sodium nitroprusside relaxations. Effects on vascular structure were assessed by lumen diameter, wall thickness and medial cross\u2010sectional area determination. Superoxide anion generation was quantified using lucigenin\u2010amplified chemiluminescence in aorta.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold>Long\u2010term daily administration of zofenopril (10\u2003mg\u00b7kg<jats:sup>\u22121<\/jats:sup>) to SHR reduced blood pressure to WKY values, decreased cardiac hypertrophy, improved the acetylcholine\u2010induced relaxant response and reversed the vascular remodelling. ACE inhibition and antioxidant activity were involved in these effects. 0.5\u2003mg\u00b7kg<jats:sup>\u22121<\/jats:sup>per day of zofenopril slightly modified blood pressure and the other effects were weaker.<\/jats:p><jats:p><jats:bold>Conclusions and implications:\u2002<\/jats:bold>Antihypertensive effects of chronic treatment with zofenopril were accompanied by recovery of endothelial function and improvement of cardiovascular structure. Low\u2010dose zofenopril had little effect on blood pressure, with some benefits on cardiovascular structure and function. Inhibition of ACE and antioxidant activity were involved in these effects.<\/jats:p>","DOI":"10.1111\/j.1476-5381.2009.00491.x","type":"journal-article","created":{"date-parts":[[2009,11,16]],"date-time":"2009-11-16T22:23:59Z","timestamp":1258410239000},"page":"1911-1921","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cardiovascular changes in spontaneously hypertensive rats are improved by chronic treatment with zofenopril"],"prefix":"10.1111","volume":"158","author":[{"given":"M","family":"G\u00f3mez\u2010Roso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MJ","family":"Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Carr\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MA","family":"Sevilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,12,8]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000166844.42227.5c"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/1753944707086350"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707746"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000163145.12707.63"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199501123320203"},{"key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6997(25)00058-4","article-title":"Bioregulation of kinins: kallikreins, kininogens, and kininases","volume":"44","author":"Bhoola KD","year":"1992","journal-title":"Pharmacol Rev"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00285-8"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(99)00042-4"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(76)90527-3"},{"key":"e_1_2_8_11_1","first-page":"126","article-title":"Are the endothelial mechanisms of ACE\u2010Is already established?","volume":"58","author":"Buczko W","year":"2006","journal-title":"Pharmacol Rep"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703498"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.87.10.840"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199203000-00005"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(02)02995-3"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00227900"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(76)90889-5"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/147323000503300103"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/66.2.416"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2003.10.016"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e31817751a7"},{"key":"e_1_2_8_22_1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0022-3565(24)39205-5","article-title":"Oxidative stress induced by tert\u2010butyl hydroperoxide causes vasoconstriction in the aorta from hypertensive and aged rats: role of cyclooxygenase\u20102 isoform","volume":"293","author":"Garcia\u2010Cohen EC","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_8_23_1","first-page":"H1535","article-title":"Mechanisms for altered endothelium\u2010dependent vasorelaxation in isolated kidneys from experimental hypertensive rats","volume":"264","author":"Hayakawa H","year":"1993","journal-title":"Am J Physiol"},{"key":"e_1_2_8_24_1","first-page":"1","article-title":"Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension","volume":"4","author":"Heran BS","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200502000-00002"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.33.6.1353"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.84.4.1589"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.37.2.541"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00944788"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e31805c9410"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.8.4.344"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2008.171"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.34.3.415"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1253\/jcj.59.624"},{"key":"e_1_2_8_35_1","first-page":"505","article-title":"Vascular remodelling","volume":"28","author":"Mulvany MJ","year":"1996","journal-title":"Hypertension"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-3623(99)00043-9"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(01)00542-3"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116491"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1991.tb01639.x"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.6.1732"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2006.09.020"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200212000-00030"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2005.07.011"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)00782-8"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199715060-00002"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.20.2.168"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026215712983"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3466.1999.tb00008.x"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.213"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2009.02.006"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)01516-3"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2004.12.008"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199711000-00014"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.09.019"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704669"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000047651.45322.16"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2009.00491.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2009.00491.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T08:05:49Z","timestamp":1739433949000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2009.00491.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["10.1111\/j.1476-5381.2009.00491.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00491.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"type":"print","value":"0007-1188"},{"type":"electronic","value":"1476-5381"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"2009-12-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}